Financhill
Sell
33

RCKT Quote, Financials, Valuation and Earnings

Last price:
$6.90
Seasonality move :
12.58%
Day range:
$6.70 - $7.29
52-week range:
$4.55 - $26.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.62x
Volume:
2.7M
Avg. volume:
3.7M
1-year change:
-69.36%
Market cap:
$750.7M
Revenue:
--
EPS (TTM):
-$2.73

Earnings Data

Next earnings date for RCKT
May 13
2025
Most recent earnings per share
-$0.62
Beat by $0.10
(Feb 27/2025)
Consensus Estimate
-$0.72
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RCKT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $1.1M -- -- -$0.59 --
05/13/2025 Q1 $800K -- -- -$0.58 --
02/27/2025 Q4 $31.3K -- -$0.62 -$0.72 $0.10
11/07/2024 Q3 -- -- -$0.71 -$0.75 $0.04
08/05/2024 Q2 -- -- -$0.74 -$0.72 -$0.02
05/06/2024 Q1 -- -- -$0.66 -$0.67 $0.01
02/26/2024 Q4 -- -- -$0.64 -$0.77 $0.13
11/06/2023 Q3 -- -- -$0.75 -$0.78 $0.03
08/09/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/04/2023 Q1 -- -- -$0.73 -$0.84 $0.11
02/27/2023 Q4 -- -- -$0.89 -$0.82 -$0.07
11/03/2022 Q3 -- -- -$0.87 -$0.77 -$0.10
08/08/2022 Q2 -- -- -$0.83 -$0.68 -$0.15
05/06/2022 Q1 -- -- -$0.67 -$0.70 $0.03
02/24/2022 Q4 -- -- -$0.69 -$0.73 $0.04
11/05/2021 Q3 -- -- -$0.79 -$0.62 -$0.17
08/09/2021 Q2 -- -- -$0.55 -$0.65 $0.10
05/10/2021 Q1 -- -- -$0.65 -$0.69 $0.04
02/25/2021 Q4 -- -- -$1.09 -$0.50 -$0.59
11/04/2020 Q3 -- -- -$0.53 -$0.45 -$0.08
08/05/2020 Q2 -- -- -$0.45 -$0.50 $0.05
05/06/2020 Q1 -- -- -$0.45 -$0.45 --
03/05/2020 Q4 -- -- -$0.39 -$0.48 $0.09
11/07/2019 Q3 -- -- -$0.38 -$0.48 $0.10
08/07/2019 Q2 -- -- -$0.38 -$0.61 $0.23
05/08/2019 Q1 -- -- -$0.43 -$0.53 $0.10
03/07/2019 Q4 -- -- -$0.66 -$0.44 -$0.22
11/07/2018 Q3 -- -- -$0.40 -$0.44 $0.04
08/08/2018 Q2 -- -- -$0.40 -$0.44 $0.04
05/11/2018 Q1 -- -- -$0.28 -$0.39 $0.11
03/06/2018 Q4 -- -- -$0.18 -$0.31 $0.13

Rocket Pharmaceuticals Earnings Questions

  • How Much did Rocket Pharmaceuticals Generate in Revenue Last Quarter?

    Rocket Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Rocket Pharmaceuticals Beat Earnings Last Quarter?

    Rocket Pharmaceuticals announced earnings per share of -$0.62 which represents a beat of analyst forecast a -$0.72 per share.

  • Is Rocket Pharmaceuticals Profitable?

    Rocket Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Rocket Pharmaceuticals EPS Next Year?

    Rocket Pharmaceuticals's earnings are forecast to decrease from -$2.73 per share to -$2.80 per share next year representing a decrease of -21.22%.

  • When is Rocket Pharmaceuticals's Earnings Date?

    Rocket Pharmaceuticals's next earnings date is May 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 7.92% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is up 0.6% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 7.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock